Sign In
Buy SPNE
$9.54
+0 (+0%)
At Close: Apr 03, 2023
SeaSpine Holdings Corporation (SPNE) CEO Keith Valentine on Q3 2021 Results - Earnings Call Transcript
05:17pm, Friday, 29'th Oct 2021
SeaSpine Holdings Corporation (SPNE) CEO Keith Valentine on Q3 2021 Results - Earnings Call Transcript
SeaSpine Holdings (SPNE) Reports Q3 Loss, Lags Revenue Estimates
07:06pm, Thursday, 28'th Oct 2021
SeaSpine (SPNE) delivered earnings and revenue surprises of -54.84% and -3.46%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
SeaSpine to Report Third Quarter 2021 Financial Results on October 28, 2021
04:05pm, Wednesday, 20'th Oct 2021
CARLSBAD, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorder
SeaSpine Announces Full Commercial Launch of The NorthStar OCT Posterior Cervical Fixation System
04:11pm, Monday, 11'th Oct 2021
CARLSBAD, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorder
SeaSpine Announces First Cases of 7D Surgical Percutaneous Spine Module for Minimally Invasive Surgery
04:05pm, Wednesday, 06'th Oct 2021
CARLSBAD, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorder
SeaSpine® Receives Innovative Technology Contract from Vizient for its 7D FLASH™ Navigation System
04:05pm, Monday, 04'th Oct 2021
Contract awarded for products that potentially bring improvement to health care industry Contract awarded for products that potentially bring improvement to health care industry
CARLSBAD, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorde
5 Stocks to Deflect Delta Variant Curveball From Orthopedic Space
09:55am, Thursday, 23'rd Sep 2021
OrthoPediatrics (KIDS), Orthofix (OFIX), Zimmer Biomet (ZBH), Stryker (SYK) and SeaSpine (SPNE) are expected to hold ground despite a challenging business climate.
SeaSpine to Participate in the Cantor Virtual Global Healthcare Conference
04:05pm, Wednesday, 22'nd Sep 2021
CARLSBAD, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorde
SeaSpine to Host Analyst & Investor Event on September 30, 2021
04:05pm, Thursday, 16'th Sep 2021
CARLSBAD, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorde
SeaSpine Announces Initial Launch of Mariner Adult Deformity System
04:05pm, Tuesday, 07'th Sep 2021
CARLSBAD, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorde
SeaSpine Holdings Corp. (SPNE) CEO Keith Valentine on Q2 2021 Results - Earnings Call Transcript
11:18pm, Monday, 02'nd Aug 2021
SeaSpine Holdings Corp. (SPNE) CEO Keith Valentine on Q2 2021 Results - Earnings Call Transcript
SeaSpine Holdings: Q2 Earnings Insights
05:14pm, Monday, 02'nd Aug 2021
Shares of SeaSpine Holdings (NASDAQ:SPNE) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 68.00% over the past year to ($0.16),
SeaSpine Stock Is Trading Higher On FDA Approval For 7D Surgical Spine Module
06:44am, Thursday, 08'th Jul 2021
The FDA has given 510(k) clearance to SeaSpine Holdings Corporation's (NASDAQ:SPNE) 7D Percutaneous Spine Module for minimally invasive surgery. This news follows SeaSpine's recent acquisition o
SeaSpine Announces FDA 510(k) Clearance of 7D Surgical Percutaneous Spine Module for Minimally Invasive Surgery
04:05pm, Wednesday, 07'th Jul 2021
CARLSBAD, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorder
